
|Articles|February 6, 2004
Age of biologics on center stage as AAD 2004 kicks off
Biologics in psoriasis are a hot buzzword asthe 62nd meeting of the American Academy of Dermatology hits stride today,with sources hailing the progression as a needed "new era." Technicalexhibits open today at 11 a.m. at the Wasington Convention Center, whilethe conference, symposia, and educational programs are in full gear.Dermatologists must enhance patients' understanding of biologics andmake them realize they have an option when other treatment modalities fail,sources added, as leveraging the patient-physician relationship is key.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














